مفید بودن توموگرافی کل بدن با فلورین-18-فلورو د اکسی گلوگز پوزیترون

چکیده  مقالات علمی چکیده این مقالات علمی که در پایگاه اطلاعاتی پاب مد قرار دارد  ترجمه خواهد شد. پاب مد بانک اطلاعاتی مقالات علوم پزشکی استSerum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.Park SJ, Sawitzki B, Kluwe L, Mautner VF, Holtkamp N, Kurtz A.BMC Med. 2013 Apr 23;11:109. doi: 10.1186/1741-7015-11-109Free PMC ArticleSelect item 229916642.Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review.Treglia G, Taralli S, Bertagna F, Salsano M, Muoio B, Novellis P, Vita ML, Maggi F, Giordano A.Radiol Res Pract. 2012;2012:431029. Epub 2012 Sep 9مفید بودن توموگرافی کل بدن با فلورین-18-فلورو د اکسی گلوگز پوزیترون در بیماران مبنلا به نوروفیبروماتوز نوع یک : مرور نظام مند Select item 229345763.Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence.Lehtonen A, Howie E, Trump D, Huson SM.Dev Med Child Neurol. 2013 Feb;55(2):111-25. doi: 10.1111/j.1469-8749.2012.04399.x. Epub 2012 Aug 31. Review.Select item 220751824.The systems biology of neurofibromatosis type 1--critical roles for microRNA.Lee MJ, Cho JH, Galas DJ, Wang K.Exp Neurol. 2012 Jun;235(2):464-8. doi: 10.1016/j.expneurol.2011.10.023. Epub 2011 Oct 31. Review.Select item 213473995.Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.Legendre CM, Charpentier-Côté C, Drouin R, Bouffard C.PLoS One. 2011 Feb 9;6(2):e16409. doi: 10.1371/journal.pone.0016409. Erratum in: PLoS One. 2011;6(4). doi: 10.1371/annotation/91535cef-2b2e-44a2-b34e-8a48863ab97d. PLoS One. 2011;6(4). doi:10.1371/annotation/7647352b-6815-480e-b37f-940f21c47058. Free PMC ArticleRelated citations Select item 179787106.[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].Bensaid B, Giammarile F, Mognetti T, Galoisy-Guibal L, Pinson S, Drouet A, Combemale P.Ann Dermatol Venereol. 2007 Oct;134(10 Pt 1):735-41. French.Select item 176364537.Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G.J Genet Couns. 2007 Aug;16(4):387-407. Epub 2007 Jul 17. Review.Select item 171891478.Orbital optic nerve gliomas in children with neurofibromatosis type 1.Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R.J AAPOS. 2006 Dec;10(6):534-9.Select item 150212349.Recent advances in neurofibromatosis type 1.Arun D, Gutmann DH.Curr Opin Neurol. 2004 Apr;17(2):101-5. Review.Select item 1201175010.[Recommendations for the treatment of neurofibromatosis type 1].Pinson S, Créange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, D'incan M, Doz F, Stoll Cl, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Lacour JP, Guillot B, Wolkenstein P; Réseau NF-France.J Fr Ophtalmol. 2002 Apr;25(4):423-33. FrenchSelect item 1170894411.Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases.Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplège A.Arch Dermatol. 2001 Nov;137(11):1421-5.Select item 966816812.Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.Klose A, Ahmadian MR, Schuelke M, Scheffzek K, Hoffmeyer S, Gewies A, Schmitz F, Kaufmann D, Peters H, Wittinghofer A, Nürnberg P.Hum Mol Genet. 1998 Aug;7(8):1261-8.Select item 934420413.Guidelines of care for neurofibromatosis type 1. American Academy of Dermatology Guidelines/Outcomes Committee.Eichenfield LF, Levy ML, Paller AS, Riccardi VM.J Am Acad Dermatol. 1997 Oct;37(4):625-30. No abstract available.Select item 891531114.Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.Wolkenstein P, Frèche B, Zeller J, Revuz J.Arch Dermatol. 1996 Nov;132(11):1333-6.